Clofarabine monotherapy in two patients with refractory Langerhans cell histiocytosis
Abstract Background Better therapeutic options other than conventional chemotherapy for pediatric patients with refractory Langerhans cell histiocytosis (LCH) remain undetermined. Case We successfully treated two patients with refractory and risk organ negative LCH with clofarabine (CLO) monotherapy...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2022-08-01
|
| Edice: | Cancer Reports |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/cnr2.1579 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|